Johnny Ek to Serve as Principal Financial Officer and Principal Accounting Officer of Akoya Biosciences, Inc

Akoya Biosciences, Inc. announced that Johnny Ek will serve as the Company's principal financial officer and principal accounting officer. Prior to joining the Company, Mr. Ek, age 47, was the Chief Financial Officer of Specific Diagnostics, Inc. from August 2021 until its acquisition by bioM rieux SA in May 2022 and served as Chief Financial Officer of the Specific Diagnostics business following the acquisition until March 2023. From February 2019 until its acquisition by Roche Holding AG in August 2021, he served as Chief Financial Officer of GenMark Diagnostics, Inc. Prior to serving as GenMark's Chief Financial Officer, Mr. Ek served as GenMark's Vice President, Finance and Accounting and Corporate Controller from November 2013 to February 2019.

Prior to that, Mr. Ek served as Vice President and International Controller for Affymetrix, Inc. from May 2013 to November 2013 and as Controller of eBioscience, Inc. from October 2010 through eBioscience's acquisition by Affymetrix in May 2013. Prior to joining eBioscience, Mr. Ek held various roles with Ernst & Young LLP from May 2001 to October 2010. Mr. Ek is a licensed Certified Public Accountant, and holds a B.S. in finance from Brigham Young University and a Master's degree in accountancy from the University of Notre Dame's Mendoza College of Business.